NewGenIvf Group Ltd is a SG-based company operating in Health Care Providers & Services industry. The company employs 76 full-time employees The company went IPO on 2022-02-15. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia, helping couples and individuals obtain access to fertility treatments. The firm offers services, such as Mitochondrial Replacement Therapy (MRT) In Reproductive, Intrauterine Insemination (IUI), MRT techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular/epididymal sperm aspiration or extraction/percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening, and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. The Company’s subsidiary is NewGenIvf Limited.
Follow-Up Questions
NewGenIvf Group Ltd 的 CEO 是誰？
Mr. Claudius Tsang 是 NewGenIvf Group Ltd 的 Chairman of the Board，自 2021 加入公司。
NIVF 股票的價格表現如何？
NIVF 的當前價格為 $1.85，在上個交易日 decreased 了 0.92%。
NewGenIvf Group Ltd 的主要業務主題或行業是什麼？
NewGenIvf Group Ltd 屬於 Health Care 行業，該板塊是 Health Care
